CLOVIS ONCOLOGY INC (NASDAQ:CLVS)

Top Analyst Upgrades and Downgrades: Apple, Blackstone, CBS, Disney, Global Payments, Netflix, Ralph Lauren, Wynn Resorts and More

Posted: September 24, 2019 at 8:50 am

Futures traded higher Tuesday morning, as the third quarter of 2019 is winding down fast. With top hedge fund and mutual fund portfolio managers looking to end the quarter on ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Apple, Barrick Gold, Domino’s, Intel, McDonald’s, Occidental, Salesforce and More

Posted: August 13, 2019 at 9:05 am

Stocks were indicated to open marginally lower on Tuesday. The market may have taken it on the chin on Monday over trade and currency fears with China, but the 1.2% ...
Read Full Story »

Friday’s Top Analyst Upgrades and Downgrades: Shopify, Qualcomm, Pinterest, Sprouts, BlackLine, Fortinet, Carbon Black and More

Posted: August 2, 2019 at 8:50 am

The stock market was doing well on Thursday following Federal Reserve Chair Jerome Powell’s decision to cut interest rates. However, this was short-lived as President Trump sent the markets tumbling ...
Read Full Story »

Why Clovis Bladder Cancer Treatment Rucaparib Is in Big Trouble

Posted: April 15, 2019 at 10:40 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares dropped on Monday after the firm announced that it would be halting its midstage trial testing its lead drug in bladder cancer patients. Management ...
Read Full Story »

Clovis Oncology Wins Big With European Patent

Posted: December 4, 2018 at 10:05 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares jumped early Tuesday after the European Patent Office upheld the company’s claims. Specifically, the European Patent Office upheld claims of European Patent 2534153 in ...
Read Full Story »

IBM, General Electric Drop into Wednesday’s 52-Week Low Club

Posted: October 31, 2018 at 3:45 pm

October 31, 2018: Here are four stocks trading with heavy volume among 159 equities making new 52-week lows by late afternoon on Wednesday. On the NYSE advancers lead decliners by ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

Posted: October 31, 2018 at 9:05 am

Stocks were indicated to open much higher on Wednesday after Tuesday's bounce, and earnings may be saving the day, on top of a strong ADP payrolls report. Some investors have ...
Read Full Story »

Keycorp, eBay Drop Into Monday’s 52-Week Low Club

Posted: October 22, 2018 at 2:00 pm

October 22, 2018: Here are four stocks trading with heavy volume among 413 equities making new 52-week lows by midday Monday. On the New York Stock Exchange, decliners lead advancers ...
Read Full Story »

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Posted: October 19, 2018 at 10:10 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares dropped on Friday after the company announced initial data from its Phase 2 TRITON2 clinical trial of Rubraca at the ESMO 2018 Congress of ...
Read Full Story »

Clovis Wins Big With FDA Update

Posted: October 2, 2018 at 12:10 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares jumped on Tuesday after the U.S. Food and Drug Administration (FDA) gave a critical update. The FDA granted Breakthrough Therapy designation for Rubraca (rucaparib) ...
Read Full Story »

Clovis Finally Faces the Music for Fraudulent Lung Cancer Drug Results

Posted: September 19, 2018 at 1:00 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares might not be showing it now, but the company is facing some heat from the U.S. Securities and Exchange Commission (SEC). The company, its ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Posted: September 11, 2018 at 10:55 am

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Clovis Breaks Into Europe With EMA Validation

Posted: July 5, 2018 at 8:55 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares saw a bump early on Thursday after the company announced that the European Medicines Agency (EMA) has validated its application for a Type 2 ...
Read Full Story »

3 Stocks to Buy Now With Up to 100% or More Upside Potential

Posted: April 11, 2018 at 8:10 am

One reason that investors continue to do business with full-service brokerage firms is they generate investment ideas, and when they make a call, they typically have solid reasons and a ...
Read Full Story »

Analyst Has 4 Favorite Biotechnology Stocks to Buy Now

Posted: March 15, 2018 at 9:40 am

Biotechnology tends to have very strong up and down moves, and last year the industry reversed the down momentum that started in 2015 and actually outperformed the S&P 500. Many ...
Read Full Story »